Literature DB >> 2311302

Repeated exposure to bacterial lipopolysaccharide interferes with disposal of pathogenic immune complexes in mice.

T Cavallo1, N A Granholm.   

Abstract

Patients with systemic lupus erythematosus (SLE) experience clinical flares in association with superimposed bacterial infection. To investigate whether heightened immune phenomena during the course of bacterial infections were related to abnormal disposal of immune complexes, we administered bacterial lipopolysaccharide (LPS) to C57BL/6 mice for 5 weeks. Control mice received vehicle only. We then challenged the mice with a subsaturating dose of radiolabelled immune complexes intravenously and determined the localization of immune complexes in liver, spleen and kidney. In comparison to control mice, mice exposed to LPS developed features of polyclonal B cell activation, autoimmune phenomena, delayed removal of immune complexes from the circulation, diminished liver uptake of immune complexes, and enhanced localization of immune complexes in the kidneys. The findings could not be attributed to biological processes dependent on complement concentration. Instead, interferences with Fc receptor function, or with endocytosis of immune complexes may represent likely possibilities. Thus, clinical flares in patients with SLE, in the presence of a superimposed infection, may result from enhanced localization of immune complexes in organs due to altered mechanisms of their disposal.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2311302      PMCID: PMC1534758          DOI: 10.1111/j.1365-2249.1990.tb05187.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  Altered glomerular permeability in the early phase of immune complex nephritis.

Authors:  T Cavallo; M Goldman; K Graves; P H Lambert
Journal:  Kidney Int       Date:  1983-11       Impact factor: 10.612

2.  The genus-specific antigen of Chlamydia: resemblance to the lipopolysaccharide of enteric bacteria.

Authors:  M Nurminen; M Leinonen; P Saikku; P H Mäkelä
Journal:  Science       Date:  1983-06-17       Impact factor: 47.728

3.  Animal model of human disease. Proliferative glomerulonephritis associated with polyclonal B-cell activation.

Authors:  T Cavallo; M Goldman; P H Lambert
Journal:  Am J Pathol       Date:  1984-02       Impact factor: 4.307

Review 4.  Characterization of the IgG response induced by polyclonal B cell activators.

Authors:  E Severinson; S Bergstedt-Lindqvist; W van der Loo; C Fernandez
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

5.  Binding, endocytosis, and degradation of model immune complexes by murine macrophages at various levels of activation.

Authors:  D S Finbloom
Journal:  Clin Immunol Immunopathol       Date:  1985-09

6.  The disappearance kinetics and glomerular deposition of small-latticed soluble immune complexes.

Authors:  A O Haakenstad; G E Striker; M Mannik
Journal:  Immunology       Date:  1982-11       Impact factor: 7.397

7.  Clearance kinetics and fate of mouse IgA immune complexes prepared with monomeric or dimeric IgA.

Authors:  A Rifai; M Mannik
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

8.  Induction of excessive B cell proliferation and differentiation by an in vitro stimulus in culture in human systemic lupus erythematosus.

Authors:  N Suzuki; T Sakane
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

9.  Salmonella bacteremia in systemic lupus erythematosus. Eight-year experience at a municipal hospital.

Authors:  S Abramson; S B Kramer; A Radin; R Holzman
Journal:  Arthritis Rheum       Date:  1985-01

10.  An improved sensitive and simple microassay of mouse complement.

Authors:  R M De Waal; G Schrijver; M J Bogman; K J Assmann; R A Koene
Journal:  J Immunol Methods       Date:  1988-04-06       Impact factor: 2.303

View more
  5 in total

1.  Prolonged circulation of immune complexes due to various altered immune functions contributes to nephritis in MRL/lpr mice.

Authors:  N A Granholm; T Cavallo
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

2.  Lipopolysaccharide from gram-negative bacteria enhances polyclonal B cell activation and exacerbates nephritis in MRL/lpr mice.

Authors:  T Cavallo; N A Granholm
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

3.  Bacterial lipopolysaccharide transforms mesangial into proliferative lupus nephritis without interfering with processing of pathogenic immune complexes in NZB/W mice.

Authors:  T Cavallo; N A Granholm
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

4.  Bacterial lipopolysaccharide induces long-lasting IgA deficiency concurrently with features of polyclonal B cell activation in normal and in lupus-prone mice.

Authors:  T Cavallo; N A Granholm
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

5.  Bacterial lipopolysaccharide enhances deposition of immune complexes and exacerbates nephritis in BXSB lupus-prone mice.

Authors:  N A Granholm; T Cavallo
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.